Alkermes plc P/FCF
What is the P/FCF of Alkermes plc?
The P/FCF of Alkermes plc is 16.62
What is the definition of P/FCF?
Price to free cash flow (P/FCF) is a valuation metric that compares the company’s current share price to its free cash flow per share.
ttm (trailing twelve months)
Price to free cash flow (P/FCF) is a measure that value investors find useful to analyze a company’s finances in relation to its current stock price. It is a stricter measure than the price to cash flow ratio as it subtracts capital expenditures from cash flow.
Free cash flow relies heavily on the state of a company's cash from operations, which is in turn heavily influenced by the company's net income. Companies can manipulate their free cash flow by lengthening the time they take to pay their bills, shortening the time it takes to collect what's owed to them, and putting off buying inventory. It also depends on what items are considered capital expenditures and this can be different in case of different companies.
Lower values of P/FCF generally indicate a company that is undervalued and whose stock is relatively cheap in relation to its free cash flow. Conversely, higher P/FCF indicate that the company's stock is relatively overvalued. Value investors thus favor companies with low or decreasing price to free cash flow values that indicate high or increasing free cash flow totals and relatively low stock share prices.
It is best to compare price to free cash flow ratios between similar companies in the same industry. However, the P/FCF metric can also be viewed over a longer time frame to see if the company's cash flow to share price value is improving or declining.
P/FCF of companies in the Health Care sector on NASDAQ compared to Alkermes plc
What does Alkermes plc do?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Companies with p/fcf similar to Alkermes plc
- Splunk Inc has P/FCF of 16.59
- Las Vegas Sands Corp has P/FCF of 16.59
- Copart has P/FCF of 16.60
- Equals plc has P/FCF of 16.60
- Fidelity National Information Services has P/FCF of 16.60
- Laboratorios Farmaceuticos Rovi, S.A has P/FCF of 16.61
- Alkermes plc has P/FCF of 16.62
- WPT Industrial Real Estate Investment Trust has P/FCF of 16.63
- Lucas Bols NV has P/FCF of 16.63
- Innovative-RFK S.p.A has P/FCF of 16.63
- CRH plc has P/FCF of 16.64
- Wyndham Destinations Inc has P/FCF of 16.64
- Enbridge has P/FCF of 16.64